Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 481–495 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2621 Myotonic Dystrophy Type 2 (DM2) Genetic Test This test identifies the CCTG repeat expansion in the CNBP gene, which is the genetic cause of Myotonic Dystrophy Type 2 (DM2). It provides a definitive molecular diagnosis for thi...	Peripheral whole blood (4 mL EDTA tube)	5 business days (sample received Monday by 11 am → report by Friday)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCTG repeat expansion in the CNBP gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Myotonic Dystrophy Type 2", "Differentiation from other myotonic myopathies", "Family history of DM2"] Measurement technique Confirm with laboratory Codes LOINC: 84512-0 ICD-10: G71.11 Clinical summary This test identifies the CCTG repeat expansion in the CNBP gene, which is the genetic cause of Myotonic Dystrophy Type 2 (DM2). It provides a definitive molecular diagnosis for this condition.
TEST-2650 NAFLD Genetic Susceptibility Panel (PNPLA3 & TM6SF2 Genotyping) Test This test identifies genetic variants (PNPLA3 I148M and TM6SF2 E167K) associated with an increased risk of developing progressive NAFLD, NASH, and fibrosis.	Peripheral whole blood (lavender-top EDTA tube)	3–4 business days (Sample Mon/Thu by 9 AM → Report Wed/Sat)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PNPLA3 rs738409 (I148M) polymorphism", "TM6SF2 rs58542926 (E167K) polymorphism"] Parameters [] Preparation ["Fast for 4 hours before collection", "Hydrate well before collection"] Indications ["Risk assessment for NAFLD progression", "Guidance for lifestyle modifications", "Monitoring for liver disease"] Measurement technique Confirm with laboratory Codes LOINC: 78051-5 ICD-10: K76.0 Clinical summary This test identifies genetic variants (PNPLA3 I148M and TM6SF2 E167K) associated with an increased risk of developing progressive NAFLD, NASH, and fibrosis.
TEST-5882 NAGA Gene Schindler Disease Genetic Test This genetic test identifies pathogenic variants in the NAGA gene associated with Schindler disease (Types I and III). It is used for diagnosis, carrier detection, and reproductive...	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	15–21 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NAGA gene", "Alpha-N-acetylgalactosaminidase (NAGA) gene sequence"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Definitive diagnosis of Schindler disease (Types I and III)", "Carrier detection in at-risk family members", "Reproductive genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81730-9 ICD-10: E77.1 Clinical summary This genetic test identifies pathogenic variants in the NAGA gene associated with Schindler disease (Types I and III). It is used for diagnosis, carrier detection, and reproductive genetic counseling.
TEST-3727 NBAS Gene Infantile Liver Failure Syndrome Type 2 Genetic Test This genetic test evaluates the NBAS gene for pathogenic variants associated with Infantile Liver Failure Syndrome Type 2 (ILFS2).	Whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NBAS gene"] Parameters [] Preparation ["No fasting or dietary restrictions are required", "Keep the child well-hydrated"] Indications ["Suspected Infantile Liver Failure Syndrome Type 2 (ILFS2)", "Recurrent acute liver failure episodes", "Family history of ILFS2"] Measurement technique Confirm with laboratory Codes LOINC: 101328-1 ICD-10: K72.00 Clinical summary This genetic test evaluates the NBAS gene for pathogenic variants associated with Infantile Liver Failure Syndrome Type 2 (ILFS2).
TEST-4097 NDRG1 Gene CMT4D Genetic Test This genetic test identifies mutations in the NDRG1 gene associated with Charcot-Marie-Tooth disease type 4D (CMT4D).	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDRG1 gene mutations", "Presence of pathogenic variants"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory", "Informed consent required"] Indications ["Suspected Charcot-Marie-Tooth disease type 4D", "Unexplained peripheral neuropathy", "Family history consistent with autosomal recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 94548-7 ICD-10: G60.0, Z82.79, Z13.71 Clinical summary This genetic test identifies mutations in the NDRG1 gene associated with Charcot-Marie-Tooth disease type 4D (CMT4D).
TEST-5124 NDUFA1 Gene Mitochondrial Complex I Deficiency NGS Test This test identifies pathogenic variants within the NDUFA1 gene, which are associated with mitochondrial complex I deficiency and related neurological disorders.	Peripheral whole blood or Buccal swab / FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFA1 gene sequence", "Copy number variants in NDUFA1 gene"] Parameters [] Preparation ["Inform phlebotomist of any anticoagulants (blood thinners) prior to collection"] Indications ["Suspected mitochondrial complex I deficiency", "Leigh syndrome", "MELAS-like phenotypes", "Progressive neurological deterioration"] Measurement technique Confirm with laboratory Codes LOINC: 99530-0 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants within the NDUFA1 gene, which are associated with mitochondrial complex I deficiency and related neurological disorders.
TEST-4625 NDUFA10 Gene Leigh Syndrome Genetic Test This test identifies pathogenic variants within the NDUFA10 gene, a primary cause of Leigh syndrome.	Peripheral Whole Blood (Venipuncture)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFA10 gene", "Single-nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Suspected Leigh syndrome based on clinical presentation", "Family history of Leigh syndrome", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21638-7 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants within the NDUFA10 gene, a primary cause of Leigh syndrome.
TEST-4659 NDUFA12 Gene Analysis (Leigh Syndrome, Complex I Deficiency) Test This test identifies pathogenic variants in the NDUFA12 gene, which are associated with Leigh syndrome (mitochondrial complex I deficiency). It uses next-generation sequencing and...	Whole Blood (EDTA) or FTA Card for Infants	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFA12 gene", "Copy Number Variations (CNVs) in NDUFA12"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory.", "Fasting is not required."] Indications ["Suspected Leigh syndrome", "Mitochondrial complex I deficiency", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G31.81 Clinical summary This test identifies pathogenic variants in the NDUFA12 gene, which are associated with Leigh syndrome (mitochondrial complex I deficiency). It uses next-generation sequencing and CNV analysis for comprehensive detection.
TEST-5137 NDUFB3 Gene Mitochondrial Complex I Deficiency Genetic Test This genetic test analyzes the NDUFB3 gene to detect mutations associated with mitochondrial Complex I deficiency.	Peripheral whole blood (EDTA tube or FTA card)	21 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFB3 gene", "Mitochondrial Complex I deficiency"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consultation"] Indications ["Suspected mitochondrial Complex I deficiency", "Neurological symptoms consistent with the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 94265-1 ICD-10: E88.49 Clinical summary This genetic test analyzes the NDUFB3 gene to detect mutations associated with mitochondrial Complex I deficiency.
TEST-5139 NDUFS2 Gene Test This test evaluates the NDUFS2 gene for mutations associated with mitochondrial complex I deficiency.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFS2 gene variants (SNVs, Indels, CNVs)", "Mitochondrial Complex I function (indirectly)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication or supplements without physician instruction"] Indications ["Suspected mitochondrial complex I deficiency", "Progressive neurological disorder of unknown origin", "Family history of mitochondrial disease"] Measurement technique Confirm with laboratory Codes LOINC: 81328-7 ICD-10: E88.49 Clinical summary This test evaluates the NDUFS2 gene for mutations associated with mitochondrial complex I deficiency.
TEST-5040 NDUFS4 Gene Sequencing (Mitochondrial Complex I Deficiency) Test This test evaluates the NDUFS4 gene for pathogenic variants associated with mitochondrial complex I deficiency.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFS4 gene coding region", "Pathogenic variants"] Parameters [] Preparation ["Participate in mandated pre-test genetic counselling session", "Do not discontinue prescribed medication without consultation"] Indications ["Suspected mitochondrial complex I deficiency", "Familial screening for mitochondrial disorders", "Guiding neurological management"] Measurement technique Confirm with laboratory Codes LOINC: 94060-0 ICD-10: E88.40 Clinical summary This test evaluates the NDUFS4 gene for pathogenic variants associated with mitochondrial complex I deficiency.
TEST-3799 NEFH Gene Amyotrophic Lateral Sclerosis Susceptibility Genetic Test This test evaluates the NEFH gene for variants associated with an increased risk of developing Amyotrophic Lateral Sclerosis (ALS).	Peripheral Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NEFH gene pathogenic variants", "Genetic susceptibility to ALS"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a family history of ALS", "Patients presenting with symptoms suggestive of ALS", "Risk assessment for individuals concerned about ALS susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 21623-1 ICD-10: Z15.89 Clinical summary This test evaluates the NEFH gene for variants associated with an increased risk of developing Amyotrophic Lateral Sclerosis (ALS).
TEST-2301 NEK1 Gene Sequencing (Short-Rib Thoracic Dysplasia Type 6 ± Polydactyly) Test This test identifies pathogenic variants in the NEK1 gene associated with Short-Rib Thoracic Dysplasia Type 6 (SRTD6). It utilizes Next-Generation Sequencing (NGS) with Sanger vali...	Whole Blood (EDTA) or FTA Card (Neonatal Heel-Stick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NEK1 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation [] Indications ["Children with suggestive radiological findings", "Children with a positive family history of SRTD6"] Measurement technique Confirm with laboratory Codes LOINC: 93442-0 ICD-10: Q77.2, Q87.8 Clinical summary This test identifies pathogenic variants in the NEK1 gene associated with Short-Rib Thoracic Dysplasia Type 6 (SRTD6). It utilizes Next-Generation Sequencing (NGS) with Sanger validation.
TEST-4362 NEXN Gene Dilated Cardiomyopathy Type 1CC Genetic Test This genetic test detects pathogenic variants in the NEXN gene associated with hereditary dilated cardiomyopathy type 1CC.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NEXN gene"] Parameters [] Preparation ["Provide a complete family history", "Attend a genetic counseling session", "No special dietary or medication restrictions"] Indications ["Diagnosis of hereditary dilated cardiomyopathy type 1CC", "Family screening for NEXN-related cardiomyopathy", "Risk stratification for sudden cardiac death", "Guidance for ICD implantation"] Measurement technique Confirm with laboratory Codes LOINC: 92742-5 ICD-10: I42.0 Clinical summary This genetic test detects pathogenic variants in the NEXN gene associated with hereditary dilated cardiomyopathy type 1CC.
TEST-2699 Next-Generation Sequencing (NGS) for Adrenoleukodystrophy (ALD) Test This test evaluates the ABCD1 gene for pathogenic variants associated with X-linked adrenoleukodystrophy (ALD) and related peroxisomal disorders.	Whole Blood	40 Working Days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCD1 gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting a physician"] Indications ["Suspected diagnosis of X-linked ALD", "Carrier screening for ABCD1 variants", "Family planning for individuals with a family history of ALD", "Evaluation of related peroxisomal disorders"] Measurement technique Confirm with laboratory Codes LOINC: 59432-9 ICD-10: E71.520 Clinical summary This test evaluates the ABCD1 gene for pathogenic variants associated with X-linked adrenoleukodystrophy (ALD) and related peroxisomal disorders.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.